vs
OPKO HEALTH, INC.（OPK）与ROGERS CORP（ROG）财务数据对比。点击上方公司名可切换其他公司
ROGERS CORP的季度营收约是OPKO HEALTH, INC.的1.4倍（$200.5M vs $148.5M），ROGERS CORP净利率更高（2.2% vs -21.1%，领先23.3%），ROGERS CORP同比增速更快（5.2% vs -19.2%），ROGERS CORP自由现金流更多（$1.1M vs $-28.6M），过去两年ROGERS CORP的营收复合增速更高（-3.3% vs -7.5%）
OPKO Health是一家聚焦诊断与医药领域的医疗企业，核心业务涵盖医疗检测与药品研发生产，在纳斯达克和特拉维夫证券交易所挂牌上市，股票代码为OPK。
罗杰斯公司是一家专注于特种工程材料研发生产的企业，总部位于美国亚利桑那州钱德勒市，其产品广泛应用于先进电子、移动通信、清洁能源、航空航天等多个高科技领域，为全球客户提供高性能材料解决方案。
OPK vs ROG — 直观对比
营收规模更大
ROG
是对方的1.4倍
$148.5M
营收增速更快
ROG
高出24.4%
-19.2%
净利率更高
ROG
高出23.3%
-21.1%
自由现金流更多
ROG
多$29.7M
$-28.6M
两年增速更快
ROG
近两年复合增速
-7.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $148.5M | $200.5M |
| 净利润 | $-31.3M | $4.5M |
| 毛利率 | 43.1% | 32.2% |
| 营业利润率 | -25.8% | — |
| 净利率 | -21.1% | 2.2% |
| 营收同比 | -19.2% | 5.2% |
| 净利润同比 | -322.8% | 421.4% |
| 每股收益（稀释后） | $-0.04 | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OPKROG
| Q1 26 | — | $200.5M | ||
| Q4 25 | $148.5M | $201.5M | ||
| Q3 25 | $151.7M | $216.0M | ||
| Q2 25 | $156.8M | $202.8M | ||
| Q1 25 | $150.0M | $190.5M | ||
| Q4 24 | $183.6M | $192.2M | ||
| Q3 24 | $173.6M | $210.3M | ||
| Q2 24 | $182.2M | $214.2M |
净利润OPKROG
| Q1 26 | — | $4.5M | ||
| Q4 25 | $-31.3M | $4.6M | ||
| Q3 25 | $21.6M | $8.6M | ||
| Q2 25 | $-148.4M | $-73.6M | ||
| Q1 25 | $-67.6M | $-1.4M | ||
| Q4 24 | $14.0M | $-500.0K | ||
| Q3 24 | $24.9M | $10.7M | ||
| Q2 24 | $-10.3M | $8.1M |
毛利率OPKROG
| Q1 26 | — | 32.2% | ||
| Q4 25 | 43.1% | 31.5% | ||
| Q3 25 | 32.9% | 33.5% | ||
| Q2 25 | 31.5% | 31.6% | ||
| Q1 25 | 28.4% | 29.9% | ||
| Q4 24 | 46.1% | 32.1% | ||
| Q3 24 | 23.1% | 35.2% | ||
| Q2 24 | 28.4% | 34.1% |
营业利润率OPKROG
| Q1 26 | — | — | ||
| Q4 25 | -25.8% | 3.5% | ||
| Q3 25 | 31.7% | 7.3% | ||
| Q2 25 | -38.3% | -33.3% | ||
| Q1 25 | -44.8% | -0.2% | ||
| Q4 24 | -18.0% | -6.6% | ||
| Q3 24 | 8.2% | 6.9% | ||
| Q2 24 | -33.9% | 5.3% |
净利率OPKROG
| Q1 26 | — | 2.2% | ||
| Q4 25 | -21.1% | 2.3% | ||
| Q3 25 | 14.3% | 4.0% | ||
| Q2 25 | -94.7% | -36.3% | ||
| Q1 25 | -45.1% | -0.7% | ||
| Q4 24 | 7.6% | -0.3% | ||
| Q3 24 | 14.3% | 5.1% | ||
| Q2 24 | -5.7% | 3.8% |
每股收益（稀释后）OPKROG
| Q1 26 | — | $0.25 | ||
| Q4 25 | $-0.04 | $0.20 | ||
| Q3 25 | $0.03 | $0.48 | ||
| Q2 25 | $-0.19 | $-4.00 | ||
| Q1 25 | $-0.10 | $-0.08 | ||
| Q4 24 | $0.02 | $-0.04 | ||
| Q3 24 | $0.03 | $0.58 | ||
| Q2 24 | $-0.01 | $0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $364.4M | $195.8M |
| 总债务越低越好 | $344.0M | — |
| 股东权益账面价值 | $1.3B | $1.2B |
| 总资产 | $1.9B | $1.4B |
| 负债/权益比越低杠杆越低 | 0.27× | — |
8季度趋势，按日历期对齐
现金及短期投资OPKROG
| Q1 26 | — | $195.8M | ||
| Q4 25 | $364.4M | $197.0M | ||
| Q3 25 | $412.0M | $167.8M | ||
| Q2 25 | $267.3M | $157.2M | ||
| Q1 25 | $428.8M | $175.6M | ||
| Q4 24 | $426.6M | $159.8M | ||
| Q3 24 | $400.1M | $146.4M | ||
| Q2 24 | $40.6M | $119.9M |
总债务OPKROG
| Q1 26 | — | — | ||
| Q4 25 | $344.0M | — | ||
| Q3 25 | $344.2M | — | ||
| Q2 25 | $343.3M | — | ||
| Q1 25 | $439.2M | — | ||
| Q4 24 | $437.2M | — | ||
| Q3 24 | $441.0M | — | ||
| Q2 24 | $201.9M | — |
股东权益OPKROG
| Q1 26 | — | $1.2B | ||
| Q4 25 | $1.3B | $1.2B | ||
| Q3 25 | $1.3B | $1.2B | ||
| Q2 25 | $1.3B | $1.2B | ||
| Q1 25 | $1.3B | $1.3B | ||
| Q4 24 | $1.4B | $1.3B | ||
| Q3 24 | $1.4B | $1.3B | ||
| Q2 24 | $1.4B | $1.3B |
总资产OPKROG
| Q1 26 | — | $1.4B | ||
| Q4 25 | $1.9B | $1.4B | ||
| Q3 25 | $2.0B | $1.4B | ||
| Q2 25 | $2.0B | $1.5B | ||
| Q1 25 | $2.1B | $1.5B | ||
| Q4 24 | $2.2B | $1.5B | ||
| Q3 24 | $2.3B | $1.5B | ||
| Q2 24 | $2.0B | $1.5B |
负债/权益比OPKROG
| Q1 26 | — | — | ||
| Q4 25 | 0.27× | — | ||
| Q3 25 | 0.26× | — | ||
| Q2 25 | 0.26× | — | ||
| Q1 25 | 0.33× | — | ||
| Q4 24 | 0.32× | — | ||
| Q3 24 | 0.31× | — | ||
| Q2 24 | 0.14× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-25.9M | $5.8M |
| 自由现金流经营现金流 - 资本支出 | $-28.6M | $1.1M |
| 自由现金流率自由现金流/营收 | -19.3% | 0.5% |
| 资本支出强度资本支出/营收 | 1.8% | 2.3% |
| 现金转化率经营现金流/净利润 | — | 1.29× |
| 过去12个月自由现金流最近4个季度 | $-190.8M | $70.1M |
8季度趋势，按日历期对齐
经营现金流OPKROG
| Q1 26 | — | $5.8M | ||
| Q4 25 | $-25.9M | $46.9M | ||
| Q3 25 | $-34.6M | $28.9M | ||
| Q2 25 | $-83.4M | $13.7M | ||
| Q1 25 | $-34.6M | $11.7M | ||
| Q4 24 | $-44.4M | $33.7M | ||
| Q3 24 | $-77.1M | $42.4M | ||
| Q2 24 | $-26.4M | $22.9M |
自由现金流OPKROG
| Q1 26 | — | $1.1M | ||
| Q4 25 | $-28.6M | $42.2M | ||
| Q3 25 | $-37.8M | $21.2M | ||
| Q2 25 | $-86.7M | $5.6M | ||
| Q1 25 | $-37.7M | $2.1M | ||
| Q4 24 | $-49.8M | $18.3M | ||
| Q3 24 | $-85.0M | $25.2M | ||
| Q2 24 | $-33.7M | $8.8M |
自由现金流率OPKROG
| Q1 26 | — | 0.5% | ||
| Q4 25 | -19.3% | 20.9% | ||
| Q3 25 | -24.9% | 9.8% | ||
| Q2 25 | -55.3% | 2.8% | ||
| Q1 25 | -25.2% | 1.1% | ||
| Q4 24 | -27.1% | 9.5% | ||
| Q3 24 | -49.0% | 12.0% | ||
| Q2 24 | -18.5% | 4.1% |
资本支出强度OPKROG
| Q1 26 | — | 2.3% | ||
| Q4 25 | 1.8% | 2.3% | ||
| Q3 25 | 2.1% | 3.6% | ||
| Q2 25 | 2.1% | 4.0% | ||
| Q1 25 | 2.1% | 5.0% | ||
| Q4 24 | 2.9% | 8.0% | ||
| Q3 24 | 4.6% | 8.2% | ||
| Q2 24 | 4.0% | 6.6% |
现金转化率OPKROG
| Q1 26 | — | 1.29× | ||
| Q4 25 | — | 10.20× | ||
| Q3 25 | -1.60× | 3.36× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -3.17× | — | ||
| Q3 24 | -3.10× | 3.96× | ||
| Q2 24 | — | 2.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OPK
| Services | $71.1M | 48% |
| Transfer Of Intellectual Property And Other | $33.7M | 23% |
| IE | $22.1M | 15% |
| Rayaldee | $8.8M | 6% |
| Barda Agreement | $6.8M | 5% |
| MX | $6.3M | 4% |
ROG
暂无分部数据
